We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells Ranks in top 10 Legal Advisers for M&A Deal Value in Q1 2014

16 April 2014

Hogan Lovells has been ranked 9th by value for global M&A deals by Thomson Reuters in the Q1 2014 M&A league tables compiled by Mergermarket, Thomson Reuters and Bloomberg.

The firm has performed solidly across a number of key regions. Notable rankings include:

  • 2nd by value for Italy (Bloomberg)
  • 4th by volume for any Italian involvement (Thomson Reuters)
  • 5th by volume for any UK involvement (Completed) (Thomson Reuters)
  • 6th by value for any Italian involvement (Thomson Reuters)
  • 7th by value for any UK involvement (Completed) (Thomson Reuters)
  • 7th by value for China (Bloomberg)
  • 9th by value for Worldwide (Completed) (Thomson Reuters)
  • 9th by value for any European involvement (Completed) (Thomson Reuters)
  • 9th by value for US Target (Completed) (Thomson Reuters)
  • 9th by value for any Japanese involvement (Completed) (Thomson Reuters)
  • 10th by value for any US involvement (Completed) (Thomson Reuters)
  • 10th by volume for Spain (Mergermarket)
  • 10th by value for any US Public involvement (Completed) (Thomson Reuters)

Commenting on the rankings Andrew Skipper and Stuart Stein, global co-heads of Hogan Lovells' corporate practice, said:

"This reflects the strong start to the year that we've had.  A number of the major transactions that we've advised on in Q1 demonstrate the benefits of our trans-Atlantic strength and regulatory capabilities.  We are seeing more appetite for deals in the market and these rankings reflect our position as a leading firm for complex high-value deals."

Market leading transactions which contributed to Hogan Lovells rankings include advising:

  • Albertsons senior management on its US$9bn acquisition of Safeway
  • GE Healthcare on its US$1.06bn acquisition of Thermo Fisher Scientific’s HyClone™
  • Investindustrial Group on its disposal by Investindustrial Group and KKR of the Avincis Group to Babcock International Group PLC for an enterprise value of approximately EUR2bn
  • Kuwait Petroleum International on its acquisition of shares in the companies containing the Retail, Supply & Distribution, Logistics and Aviation businesses of Shell in Italy.

Loading data